TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
TargetGalanin receptor type 3(Homo sapiens (Human))
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Synaptic Pharmaceutical
Curated by PDSP Ki Database
Affinity DataIC50: 0.0200nMAssay Description:Antagonist activity at human AR in MDA-MB453-MMTV-luci cells by functional assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.800nMAssay Description:Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.800nMAssay Description:Antagonist activity at human AR in MDA-MB453-MMTV-luci cells by functional assayMore data for this Ligand-Target Pair
Affinity DataIC50: >1nMAssay Description:Antagonist activity at human AR in MDA-MB453-MMTV-luci cells by functional assayMore data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of recombinant human CLK1 expressed in insect cells using ERMRPRKRQGSVRRRV peptide as substrate after 40 mins in presence of [gamma-33P]-A...More data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Sichuan University And Collaborative Innovation Center For Biotherapy
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of recombinant human CLK1 expressed in insect cells using ERMRPRKRQGSVRRRV peptide as substrate after 40 mins in presence of [gamma-33P]-A...More data for this Ligand-Target Pair
Affinity DataIC50: 3nMpH: 8.5 T: 2°CAssay Description:Inhibitory effect of compounds was determined in a cell free fluorescence assay. The H2O2 generated from the degradation of D-serine was linked to ox...More data for this Ligand-Target Pair
Affinity DataIC50: 3nMpH: 8.5 T: 2°CAssay Description:Inhibitory effect of compounds was determined in a cell free fluorescence assay. The H2O2 generated from the degradation of D-serine was linked to ox...More data for this Ligand-Target Pair
Affinity DataIC50: 3.80nMAssay Description:Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 4nMpH: 8.5 T: 2°CAssay Description:Inhibitory effect of compounds was determined in a cell free fluorescence assay. The H2O2 generated from the degradation of D-serine was linked to ox...More data for this Ligand-Target Pair
Affinity DataIC50: 4nMpH: 8.5 T: 2°CAssay Description:Inhibitory effect of compounds was determined in a cell free fluorescence assay. The H2O2 generated from the degradation of D-serine was linked to ox...More data for this Ligand-Target Pair
Affinity DataIC50: 4nMAssay Description:Inhibitory effect of compounds was determined in a cell free fluorescence assay. The H2O2 generated from the degradation of D-serine was linked to ox...More data for this Ligand-Target Pair
TargetSodium channel protein type 2 subunit alpha(Rattus norvegicus)
Cambridge Neuroscience
Curated by ChEMBL
Cambridge Neuroscience
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:In vitro inhibition of [14C]- guanidinium influx in Chinese hamster ovary (CHO) cells expressing rat brain sodium channel type IIA (CNaIIA-1)More data for this Ligand-Target Pair
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
Cambridge Neuroscience
Curated by ChEMBL
Cambridge Neuroscience
Curated by ChEMBL
Affinity DataIC50: 4.5nMAssay Description:Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensionsMore data for this Ligand-Target Pair
Affinity DataIC50: 5nMpH: 8.5 T: 2°CAssay Description:Inhibitory effect of compounds was determined in a cell free fluorescence assay. The H2O2 generated from the degradation of D-serine was linked to ox...More data for this Ligand-Target Pair